W STRATEGIES, LLC for GLAXOSMITHKLINE
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education about the importance of vaccines, especially in the adult population. Education about drug importation. Education about regulatory and legislative obstacles to value based arrangements between manufacturers and payers. Prescription Drug User Fee Act (PDUFA) Reauthorization. FDA OTC Monograph reform. H.R.1628: American Health Care Act. Better Care Reconciliation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Budget/Appropriations BUD
FY 2018 Labor/HHS appropriations bill with respect to biosecurity.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program and changes to copay structure for low income beneficiaries.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.